GH Research Plc (GHRS)
20.44
+1.28
(+6.68%)
USD |
NASDAQ |
Apr 30, 16:00
20.44
0.00 (0.00%)
After-Hours: 19:54
GH Research EPS Diluted (Quarterly) : -0.2279 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | -0.5106 |
| Compass Pathways Plc | -1.001 |
| Atai Beckley, Inc. | -1.734 |
| Jazz Pharmaceuticals Plc | 3.207 |
| Nektar Therapeutics | -1.778 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.14M |
| Total Expenses (Quarterly) | 14.14M |
| Enterprise Value | 908.29M |
| Earnings Yield | -3.86% |
| Normalized Earnings Yield | -4.340 |